{"id":"https://openalex.org/W2071924796","doi":"https://doi.org/10.1002/hec.1549","title":"Investment in antiviral drugs: a real options approach","display_name":"Investment in antiviral drugs: a real options approach","publication_year":2009,"publication_date":"2009-10-08","ids":{"openalex":"https://openalex.org/W2071924796","doi":"https://doi.org/10.1002/hec.1549","mag":"2071924796","pmid":"https://pubmed.ncbi.nlm.nih.gov/19816857"},"language":"en","primary_location":{"id":"doi:10.1002/hec.1549","doi":"https://doi.org/10.1002/hec.1549","is_oa":true,"landing_page_url":"https://doi.org/10.1002/hec.1549","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hec.1549","source":{"id":"https://openalex.org/S145200904","display_name":"Health Economics","issn_l":"1057-9230","issn":["1057-9230","1099-1050"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a-star","anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","fnege-2","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health Economics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hec.1549","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082166488","display_name":"Arthur E. Attema","orcid":"https://orcid.org/0000-0003-3607-6579","observed_orcids":["https://orcid.org/0000-0003-3607-6579"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]},{"id":"https://openalex.org/I4210104433","display_name":"National Institute for Public Health and the Environment","ror":"https://ror.org/01cesdt21","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210104433"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Arthur E. Attema","raw_affiliation_strings":["Center for Prevention and Health Services Research, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands","iBMG/iMTA, Erasmus University Medical Center, Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Prevention and Health Services Research, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands","institution_ids":["https://openalex.org/I4210104433"]},{"raw_affiliation_string":"iBMG/iMTA, Erasmus University Medical Center, Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047866823","display_name":"Anna K. Lugn\u00e9r","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104433","display_name":"National Institute for Public Health and the Environment","ror":"https://ror.org/01cesdt21","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210104433"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Anna K. Lugn\u00e9r","raw_affiliation_strings":["Center for Infectious Disease Control Netherlands, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Infectious Disease Control Netherlands, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands","institution_ids":["https://openalex.org/I4210104433"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001619297","display_name":"Talitha Feenstra","orcid":"https://orcid.org/0000-0002-5788-0454","observed_orcids":["https://orcid.org/0000-0002-5788-0454"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]},{"id":"https://openalex.org/I4210104433","display_name":"National Institute for Public Health and the Environment","ror":"https://ror.org/01cesdt21","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210104433"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Talitha L. Feenstra","raw_affiliation_strings":["Center for Prevention and Health Services Research, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands","Department of Epidemiology, University Medical Center Groningen, Groningen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Prevention and Health Services Research, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands","institution_ids":["https://openalex.org/I4210104433"]},{"raw_affiliation_string":"Department of Epidemiology, University Medical Center Groningen, Groningen, The Netherlands","institution_ids":["https://openalex.org/I1334415907"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5001619297"],"corresponding_institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I4210104433"],"apc_list":{"value":4050,"currency":"USD","value_usd":4050},"apc_paid":{"value":4050,"currency":"USD","value_usd":4050},"fwci":2.2469,"has_fulltext":true,"cited_by_count":25,"citation_normalized_percentile":{"value":0.91221966,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"19","issue":"10","first_page":"1240","last_page":"1254"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11976","display_name":"Capital Investment and Risk Analysis","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2003","display_name":"Finance"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11976","display_name":"Capital Investment and Risk Analysis","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2003","display_name":"Finance"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/real-options","display_name":"real options","score":0.7929999828338623},{"id":"https://openalex.org/keywords/antiviral-agents","display_name":"antiviral agents","score":0.9269999861717224},{"id":"https://openalex.org/keywords/pandemic-influenza","display_name":"pandemic influenza","score":0.6359999775886536},{"id":"https://openalex.org/keywords/stockpiling","display_name":"stockpiling","score":0.7940000295639038},{"id":"https://openalex.org/keywords/risk-aversion","display_name":"risk aversion","score":0.9629999995231628},{"id":"https://openalex.org/keywords/expected-utility","display_name":"expected utility","score":0.5740000009536743},{"id":"https://openalex.org/keywords/investment-under-uncertainty","display_name":"investment under uncertainty","score":0.8740000128746033},{"id":"https://openalex.org/keywords/health-policy","display_name":"health policy","score":0.9070000052452087},{"id":"https://openalex.org/keywords/value-of-information","display_name":"value of information","score":0.8730000257492065}],"concepts":[{"id":"https://openalex.org/C27548731","wikidata":"https://www.wikidata.org/wiki/Q88272","display_name":"Investment (military)","level":3,"score":0.4821983873844147},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.4450475871562958},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37648922204971313},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.35706228017807007},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.3311879634857178},{"id":"https://openalex.org/C162118730","wikidata":"https://www.wikidata.org/wiki/Q1128453","display_name":"Actuarial science","level":1,"score":0.3262198865413666},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.08460992574691772},{"id":"https://openalex.org/C94625758","wikidata":"https://www.wikidata.org/wiki/Q7163","display_name":"Politics","level":2,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000600","qualifier_name":"supply & distribution","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003365","descriptor_name":"Costs and Cost Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006296","descriptor_name":"Health Services","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D006296","descriptor_name":"Health Services","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007251","descriptor_name":"Influenza, Human","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007251","descriptor_name":"Influenza, Human","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018803","descriptor_name":"Models, Economic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D035501","descriptor_name":"Uncertainty","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058873","descriptor_name":"Pandemics","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true}],"locations_count":7,"locations":[{"id":"doi:10.1002/hec.1549","doi":"https://doi.org/10.1002/hec.1549","is_oa":true,"landing_page_url":"https://doi.org/10.1002/hec.1549","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hec.1549","source":{"id":"https://openalex.org/S145200904","display_name":"Health Economics","issn_l":"1057-9230","issn":["1057-9230","1099-1050"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a-star","anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","fnege-2","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health Economics","raw_type":"journal-article"},{"id":"pmid:19816857","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19816857","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health economics","raw_type":"Journal Article"},{"id":"pmh:oai:pure.eur.nl:openaire_cris_publications/3dcb9baf-ad08-478e-bc1a-a5eb635a001b","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/3dcb9baf-ad08-478e-bc1a-a5eb635a001b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Attema, A, Lugn\u00e9r, AK & Feenstra, TL 2010, 'Investment in antiviral drugs: a real options approach', Health Economics, vol. 19, pp. 1240-1254. https://doi.org/10.1002/hec.1549","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:eur:oai:pure.eur.nl:publications/3dcb9baf-ad08-478e-bc1a-a5eb635a001b","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/3dcb9baf-ad08-478e-bc1a-a5eb635a001b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Health Economics, 19, 1240 - 1254. John Wiley & Sons Ltd.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.rug.nl:openaire/7d455235-d1b5-4305-8a4b-f59d393225c6","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/files/6752497/Attema2011HealthEcon.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Attema, A E, Lugner, A K & Feenstra, T L 2010, 'INVESTMENT IN ANTIVIRAL DRUGS : A REAL OPTIONS APPROACH', Health Economics, vol. 19, no. 10, pp. 1240-1254. https://doi.org/10.1002/hec.1549","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:rivm.openrepository.com:10029/644501","doi":null,"is_oa":false,"landing_page_url":"https://rivm.openrepository.com/handle/10029/644501","pdf_url":null,"source":{"id":"https://openalex.org/S4306401814","display_name":"Rivm Repository (Netherlands National Institute for Public Health and the Environment)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210104433","host_organization_name":"National Institute for Public Health and the Environment","host_organization_lineage":["https://openalex.org/I4210104433"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/7d455235-d1b5-4305-8a4b-f59d393225c6","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/en/publications/7d455235-d1b5-4305-8a4b-f59d393225c6","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Health Economics, 19(10), 1240 - 1254. Wiley-Blackwell","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1002/hec.1549","doi":"https://doi.org/10.1002/hec.1549","is_oa":true,"landing_page_url":"https://doi.org/10.1002/hec.1549","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hec.1549","source":{"id":"https://openalex.org/S145200904","display_name":"Health Economics","issn_l":"1057-9230","issn":["1057-9230","1099-1050"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a-star","anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","fnege-2","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health Economics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.4043000042438507,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2071924796.pdf","grobid_xml":"https://content.openalex.org/works/W2071924796.grobid-xml"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W1532768477","https://openalex.org/W1548953477","https://openalex.org/W1559694472","https://openalex.org/W1571272128","https://openalex.org/W1984421215","https://openalex.org/W1995503011","https://openalex.org/W2001445607","https://openalex.org/W2002444764","https://openalex.org/W2005608328","https://openalex.org/W2041652700","https://openalex.org/W2041946752","https://openalex.org/W2043727502","https://openalex.org/W2049391836","https://openalex.org/W2063865663","https://openalex.org/W2066508166","https://openalex.org/W2068496814","https://openalex.org/W2071434182","https://openalex.org/W2074479676","https://openalex.org/W2081230494","https://openalex.org/W2083791720","https://openalex.org/W2083973672","https://openalex.org/W2087137161","https://openalex.org/W2091263072","https://openalex.org/W2098782379","https://openalex.org/W2107093750","https://openalex.org/W2110424412","https://openalex.org/W2114722302","https://openalex.org/W2116070369","https://openalex.org/W2119611042","https://openalex.org/W2129087050","https://openalex.org/W2130190682","https://openalex.org/W2130338949","https://openalex.org/W2133469585","https://openalex.org/W2138351910","https://openalex.org/W2150552447","https://openalex.org/W2154914850","https://openalex.org/W2156866338","https://openalex.org/W2163737296","https://openalex.org/W2165758480","https://openalex.org/W2174838819","https://openalex.org/W2412164826","https://openalex.org/W3011865677","https://openalex.org/W3125353710","https://openalex.org/W4365787967","https://openalex.org/W7033623382"],"related_works":["https://openalex.org/W2174838819","https://openalex.org/W2385028678","https://openalex.org/W2567113127","https://openalex.org/W1540718487","https://openalex.org/W2099397021","https://openalex.org/W2060354787","https://openalex.org/W2390912593","https://openalex.org/W2387487789","https://openalex.org/W2034675022","https://openalex.org/W2123204820"],"abstract_inverted_index":{"Real":[0],"options":[1,35,77,95],"analysis":[2,96,116],"is":[3,66],"a":[4,23,27,82,108],"promising":[5],"approach":[6,15,36],"to":[7,16,37,56,69,75],"model":[8,106],"investment":[9,58],"under":[10],"uncertainty.":[11],"We":[12,48],"employ":[13],"this":[14,60],"value":[17,113],"stockpiling":[18],"of":[19,32,62,72,93,104,114],"antiviral":[20],"drugs":[21],"as":[22],"precautionary":[24,63],"measure":[25],"against":[26],"possible":[28],"influenza":[29],"pandemic.":[30],"Modifications":[31],"the":[33,54,91,105,111],"real":[34,76,86,94],"include":[38],"risk":[39,51,73],"attitude":[40],"and":[41,89,107],"deviations":[42],"from":[43],"expected":[44,112],"utility":[45],"are":[46,117],"presented.":[47],"show":[49],"that":[50],"aversion":[52,74],"counteracts":[53],"tendency":[55],"delay":[57],"for":[59,97,101],"case":[61],"investment,":[64],"which":[65],"in":[67],"contrast":[68],"earlier":[70],"applications":[71],"analysis.":[78],"Moreover,":[79],"we":[80],"provide":[81],"numerical":[83],"example":[84],"using":[85],"world":[87],"data":[88],"discuss":[90],"implications":[92],"health":[98],"policy.":[99],"Suggestions":[100],"further":[102],"extensions":[103],"comparison":[109],"with":[110],"information":[115],"put":[118],"forward.":[119]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}